Assignee
ARCH ONCOLOGY INC
US·8 granted patents·12 pending applications·46 citations·filing 2016–2022
Top patents by PatentIndex Score
20 records- 0197US10259873B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2016·Granted Apr 16, 2019·21 cites·4 claims
- 0291US10239945B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Mar 26, 2019·13 cites·14 claims
- 0390US10844124B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Nov 24, 2020·6 cites·13 claims
- 0490US10669336B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Jun 2, 2020·4 cites·2 claims
- 0585US10676524B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Jun 9, 2020·2 cites·4 claims
- 0681US2023192849A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 0770US11292834B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Apr 5, 2022·0 cites·6 claims
- 0865US2021079091A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0964US11692035B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Jul 4, 2023·0 cites·17 claims
- 1064US2019112373A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 1164US2021070865A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1257US2022251191A1Therapeutic compositions and methods for treating cancer in combination with analogs of interleukin proteinsARCH ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1354US2022226469A1Therapeutic sirp-alpha antibodiesARCH ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1453US2022313819A1Combination therapy for the treatment of solid and hematological cancersARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1552US11202828B2Therapeutic SIRP-α antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Dec 21, 2021·0 cites·21 claims
- 1648US2021324075A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1746US2022185886A1Methods for identifying biomarkers to predict treatment responseARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1845US2023279108A1Therapeutic sirp-alpha antibodiesARCH ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1944US2021395831A1Biomarkers to improve efficacy of cancer immunotherapyARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2043US2019309066A1Combination therapy for the treatment of solid and hematological cancersARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ARCH ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →